Product Information

NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2221 per GM under NDC 45802088094. Its NADAC has been published 462 times since Jan 10, 2018.

FDA first approved this application on Aug 14, 2017. Its Orange Book therapeutic-equivalence code is AT.

NYSTATIN-TRIAMCINOLONE CREAM

nystatin, triamcinolone acetonide
$0.2221per GM

Strength

100000; 1 [USP'U]/g; mg/g

NDC

45802088094

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208479

FDA Approved

8/14/2017

TE Code

AT

On Market Since

11/27/2017

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid
Polyene Antifungal
Polyenes

Price Statistics

The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 462 times since Jan 10, 2018, and over the history we have for it it has declined 90.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2221 per GM
All-time high$2.2340 (Jan 10, 2018)
All-time low$0.2047 (Nov 20, 2024)
52-week high$0.2433
52-week low$0.2127
Median price$0.4423
Average price$0.5654
Largest weekly change+81.7% (Aug 21, 2024)
Weeks tracked462
Tracking sinceJan 10, 2018

Price History

1W

0.0%

1M

-1.1%

3M

-0.1%

6M

-1.6%

1Y

-16.0%

3Y

-40.0%

5Y

-61.2%

All

-90.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 16%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?

The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2221 per GM (NDC 45802088094), effective Nov 11, 2026.

How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?

Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 90.1%. It has been tracked across 462 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?

Since Jan 10, 2018, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.2047 (Nov 20, 2024) to a high of $2.2340 (Jan 10, 2018), with a median of $0.4423 per GM.

Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE CREAM, is $0.1869 per GM — about 16% below NYSTATIN-TRIAMCINOLONE CREAM.

Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?

NYSTATIN-TRIAMCINOLONE CREAM (NDC 45802088094) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.